Cantor Fitzgerald adjusted its outlook on Informatica (NYSE:INFA) shares by lowering the price target to $18.00 from the ...
Cantor Fitzgerald reaffirmed its Overweight rating and $118.00 price target for Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company specializing in rare diseases. Currently ...
Lutnick, President Donald Trump's nominee to head the Commerce Department, won the bonus for work he did on behalf of Newmark ...
Stock analysts at Cantor Fitzgerald issued their FY2025 earnings per share estimates for Axsome Therapeutics in a note issued ...
Cantor Fitzgerald Investment Advisors L.P. decreased its stake in shares of Meta Platforms, Inc. (NASDAQ:META – Free Report) by 1.6% in the fourth quarter, according to its most recent 13F filing with ...
President Donald Trump’s nominee for U.S. Secretary of Commerce, Howard Lutnick, passed a key procedural vote in the Senate on Thursday, clearing the path for his final confirmation vote.
CVS Health (CVS) stock was upgraded by Cantor Fitzgerald to Overweight after the company posted strong Q4 results earlier in ...
It’s not that the Trump administration is anti-Goldman Sachs, sources say, but rather there just isn’t as much talent to take ...
A U.S. Senate committee voted on Wednesday to advance President Donald Trump's nominee Howard Lutnick, billionaire chairman ...
Cantor Fitzgerald came out and expressed concerns around the Magnificent Seven group, saying the stocks are “vulnerable,” suggesting that there could be a shift in fund flows towards different ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results